CuraSen Therapeutics, Inc.
5 clinical trials · Sponsor
◉ Watch CuraSen Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study in Subjects With Neurogenic Orthostatic Hypotension (NCT07089043) | CuraSen Therapeutics, Inc. | 2025-09-12 |
| A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait (CLIN-012) (NCT04935762) | CuraSen Therapeutics, Inc. | 2024-06-01 |
| A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease (NCT05104463) | CuraSen Therapeutics, Inc. | 2022-04-11 |
| A Study of CST-2032 in Subjects With Cognitive Impairment (NCT05033912) | CuraSen Therapeutics, Inc. | 2021-10-01 |
| A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders (NCT04739423) | CuraSen Therapeutics, Inc. | 2021-06-28 |
Track CuraSen Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.